Primary hyperparathyroidism associated with MEN 1: Experience in 71 cases

被引:4
作者
Balsalobre Salmeron, Maria [1 ]
Rodriguez Gonzalez, Jose Manuel [2 ]
Rios, Antonio [2 ]
Febrero, Beatriz [2 ]
Parrilla Paricio, Pascual [2 ]
机构
[1] Hosp Univ Santa Lucia, Unidad Cirugia Endocrina, Murcia, Spain
[2] Hosp Univ Virgen Arrixaca, Unidad Cirugia Endocrina, Murcia, Spain
来源
CIRUGIA ESPANOLA | 2018年 / 96卷 / 10期
关键词
Hyperparathyroidism; MEN; 1; Recurrence; Treatment; ENDOCRINE NEOPLASIA TYPE-1; PARATHYROIDECTOMY; DIAGNOSIS;
D O I
10.1016/j.ciresp.2018.06.014
中图分类号
R61 [外科手术学];
学科分类号
摘要
Introduction: Primary hyperparathyroidism (pHPT) in MEN 1 is characterized by multiglandular disease and early involvement of parathyroid glands at different times. Persistence and recurrence range from 25%-35%. The purpose was: a) to describe the experience and the treatment of patients with pHPT in MEN 1; b) to analyze the variables related with clinical presentation and recurrence. Method: A total of 97 patients with MEN 1 were diagnosed in a tertiary hospital. A retrospective analysis was made in patients with pHPT (n = 71). Study variables: age at diagnosis, mutation, clinical presentation, laboratory tests, surgical technique, and recurrence of HPT. Results: Mean age was 38 years, and 50 patients were asymptomatic. The surgical technique was: subtotal parathyroidectomy (n = 55), resection of three glands (n = 7), and resection of less glands (n = 9). Transcervical thymectomy was performed in 53 patients. Mean follow-up was 102.9 months. There were 21 recurrences, There were correlations between age at diagnosis and serum calcium levels with the presence of symptoms (P < .0001). There were also correlations between recurrence and surgical technique (P <.03), non-association with thymectomy (P <. 0001), and follow-up time (P <.03). Conclusion: Performing genetic and clinical screening allows us to make a diagnosis in the asymptomatic period and to provide early treatment for HPT in MEN 1. The recurrence rate is high, and follow-up time and the surgical technique used are risk factors for recurrence. (C) 2018 AEC. Published by Elsevier Espana, S.L.U. All rights reserved.
引用
收藏
页码:627 / 633
页数:7
相关论文
共 29 条
[1]   HYPERPARATHYROIDISM PRESENTING AS THE 1ST LESION IN MULTIPLE ENDOCRINE NEOPLASIA TYPE-1 [J].
BENSON, L ;
LJUNGHALL, S ;
AKERSTROM, G ;
OBERG, K .
AMERICAN JOURNAL OF MEDICINE, 1987, 82 (04) :731-737
[2]   FAMILIAL MULTIPLE ENDOCRINE NEOPLASIA TYPE-I - A NEW LOOK AT PATHOPHYSIOLOGY [J].
BRANDI, ML ;
MARX, SJ ;
AURBACH, GD ;
FITZPATRICK, LA .
ENDOCRINE REVIEWS, 1987, 8 (04) :391-405
[3]   The outcome of subtotal parathyroidectomy for the treatment of hyperparathyroidism in multiple endocrine neoplasia type 1 [J].
Burgess, JR ;
David, R ;
Parameswaran, V ;
Greenaway, TM ;
Shepherd, JJ .
ARCHIVES OF SURGERY, 1998, 133 (02) :126-129
[4]   Osteoporosis in multiple endocrine neoplasia type 1 -: Severity, clinical significance, relationship to primary hyperparathyroidism, and response to parathyroidectomy [J].
Burgess, JR ;
David, R ;
Greenaway, TM ;
Parameswaran, V ;
Shepherd, JJ .
ARCHIVES OF SURGERY, 1999, 134 (10) :1119-1123
[5]   Post-surgical follow-up of primary hyperparathyroidism associated with multiple endocrine neoplasia type 1 [J].
Coutinho, Flavia L. ;
Lourenco, Delmar M., Jr. ;
Toledo, Rodrigo A. ;
Montenegro, Fabio L. M. ;
Toledo, Sergio P. A. .
CLINICS, 2012, 67 :169-172
[6]  
d'Alessandro AF, 2012, REV ASSOC MED BRAS, V58, P323
[7]   Multiple endocrine neoplasia type 1 parathyroid adenoma development over time [J].
Doherty, GM ;
Lairmore, TC ;
DeBenedetti, MK .
WORLD JOURNAL OF SURGERY, 2004, 28 (11) :1139-1142
[8]  
Dotzenrath C, 2001, EUR J SURG, V167, P173
[9]   Long-Term Surveillance of Treated Hyperparathyroidism for Multiple Endocrine Neoplasia Type 1: Recurrence or Hypoparathyroidism? [J].
Fyrsten, Ellen ;
Norlen, Olov ;
Hessman, Ola ;
Stalberg, Peter ;
Hellman, Per .
WORLD JOURNAL OF SURGERY, 2016, 40 (03) :615-621
[10]  
Gaztambide S, 2013, MINERVA ENDOCRINOL, V38, P17